US Stocks

PATH Stock Rises 1.44% in Pre-Market: UiPath Inc. (NYSE) April 21

April 21, 2026
7 min read

UiPath Inc. (PATH) stock climbed 1.44% to $10.56 in pre-market trading on April 21, 2026. The robotic process automation leader trades on the NYSE with a market cap of $5.65 billion USD. PATH stock has faced headwinds this year, down 35.54% year-to-date, but recent momentum shows signs of stabilization. The company’s automation platform serves banking, healthcare, and government sectors globally. With earnings due May 28, investors are watching PATH stock closely for signs of recovery in the competitive AI infrastructure space.

PATH Stock Price Action and Technical Setup

UiPath Inc. stock opened at $10.38 and reached a day high of $10.72 before settling at $10.56, up $0.15 from the previous close of $10.41. Trading volume came in at 12.6 million shares, representing just 37% of the average daily volume of 32.1 million. The stock trades well below its 52-week high of $19.84 but above its 52-week low of $9.28. Technical indicators show PATH stock trading near its 50-day moving average of $11.20 and significantly below its 200-day average of $13.21. The relative strength index (RSI) sits at 46.25, suggesting neither overbought nor oversold conditions. Bollinger Bands show the stock trading between $9.57 and $11.85, indicating moderate volatility in the current range.

Meyka AI Grade and Analyst Consensus on PATH Stock

Meyka AI rates PATH with a grade of B+, reflecting a balanced outlook for UiPath Inc. stock. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. The rating is not guaranteed and we are not financial advisors. Analyst sentiment remains mixed, with 2 buy ratings, 12 hold ratings, and 1 sell rating among tracked analysts. The consensus rating sits at 3.0, indicating a neutral-to-hold stance. Recent momentum analysis shows PATH stock underperforming the S&P 500 over multiple timeframes. No price target consensus is currently available, though individual analysts have provided guidance ranging around current levels.

PATH Stock Valuation and Financial Metrics

UiPath Inc. stock trades at a P/E ratio of 20.32, slightly elevated compared to technology sector averages. The price-to-sales ratio stands at 3.50, reflecting premium valuation typical of software infrastructure companies. PATH stock shows a PEG ratio of 0.84, suggesting reasonable valuation relative to growth expectations. The company maintains a strong balance sheet with a current ratio of 2.48, indicating solid short-term liquidity. Earnings per share (EPS) reached $0.52 trailing twelve months, with net profit margin at 17.5%. Free cash flow per share stands at $0.66, while operating cash flow per share is $0.69. The debt-to-equity ratio remains minimal at 0.034, showing PATH stock backed by conservative capital structure. Track PATH on Meyka for real-time updates on these key metrics.

PATH Stock Growth Drivers and Market Position

UiPath Inc. delivered 9.3% revenue growth in the latest fiscal year, with net income climbing 18% year-over-year. Earnings per share grew 18.75%, outpacing revenue growth and reflecting operational leverage. The company’s gross profit margin remains robust at 83.2%, demonstrating strong pricing power in the RPA market. Operating cash flow grew 7.2% while free cash flow increased 4.8%, showing consistent cash generation. Research and development spending jumped 14.6%, indicating PATH stock is investing heavily in AI-powered automation capabilities. The company operates with 3,868 full-time employees across offices in the United States, Romania, and Japan. UiPath’s platform combines artificial intelligence with low-code development, enabling enterprises to automate complex business processes without extensive coding knowledge.

PATH Stock Price Forecast and Market Sentiment

Meyka AI’s forecast model projects PATH stock reaching $14.15 over the next twelve months, implying 34% upside from current levels. The quarterly forecast suggests $10.52, while the three-year projection targets $13.13. These forecasts are model-based projections and not guarantees. The five-year outlook shows $12.18, indicating modest long-term appreciation potential. Current analyst price target sits at $14.07, closely aligned with Meyka’s yearly projection. PATH stock has recovered 1.49% over the past day and 3.58% over five days, suggesting recent buying interest. However, the stock remains down 12.4% over one month and 26.5% over three months, reflecting broader market concerns about software valuations and RPA adoption rates.

Market Sentiment: Trading Activity and Liquidation Signals

Pre-market trading volume for PATH stock remains subdued at 37% of average daily volume, typical for early session activity. The money flow index (MFI) reads 51.21, indicating balanced buying and selling pressure without extreme accumulation or distribution. On-balance volume (OBV) shows -129.4 million, suggesting net selling pressure over recent sessions. The MACD indicator displays -0.32 with signal line at -0.34, showing bearish momentum crossover. However, the histogram value of 0.02 indicates early signs of momentum reversal. The average directional index (ADX) sits at 22.90, suggesting moderate trend strength without clear directional conviction. Stochastic indicators show %K at 58.26 and %D at 56.75, approaching overbought territory but not yet extreme. These technical signals suggest PATH stock may be consolidating before the next significant move.

Final Thoughts

UiPath Inc. (PATH) stock shows mixed signals as it trades near $10.56 in pre-market activity on April 21, 2026. The 1.44% gain reflects modest buying interest, though trading volume remains light. Meyka AI’s B+ grade and analyst consensus of 3.0 (hold) suggest cautious optimism about PATH stock’s near-term prospects. The company’s strong fundamentals, including 18% net income growth and 83.2% gross margins, support the bull case. However, PATH stock’s 35.5% year-to-date decline and valuation concerns weigh on sentiment. The $14.15 twelve-month price target implies meaningful upside, but execution risk remains. Investors should monitor the May 28 earnings announcement closely, as results will likely drive significant PATH stock movement. The automation and AI infrastructure space remains competitive, making PATH stock suitable primarily for growth-oriented investors with higher risk tolerance.

FAQs

What is the current PATH stock price and trading volume?

UiPath Inc. (PATH) trades at $10.56 USD on the NYSE, up 1.44% in pre-market activity. Daily trading volume stands at 12.6 million shares, representing 37% of the 32.1 million average daily volume. The stock trades between its 52-week low of $9.28 and high of $19.84.

What is Meyka AI’s rating for PATH stock?

Meyka AI rates PATH with a B+ grade based on S&P 500 comparison, sector performance, financial growth, and analyst consensus. This grade is not guaranteed and we are not financial advisors. The rating suggests a balanced outlook for UiPath Inc. stock.

What is the PATH stock price forecast for 2026?

Meyka AI projects PATH stock reaching $14.15 over twelve months, implying 34% upside from current levels. The quarterly forecast is $10.52, while the three-year target is $13.13. These forecasts are model-based projections and not guaranteed.

What are analyst ratings for PATH stock?

Analyst consensus shows 2 buy ratings, 12 hold ratings, and 1 sell rating for UiPath Inc. stock. The consensus rating is 3.0, indicating a neutral-to-hold stance. No price target consensus is currently available.

When is UiPath’s next earnings announcement?

UiPath Inc. will announce earnings on May 28, 2026 at 4:00 PM ET. This earnings report will be critical for PATH stock, as it will provide updates on revenue growth, profitability, and forward guidance for the automation platform.

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.

What brings you to Meyka?

Pick what interests you most and we will get you started.

I'm here to read news

Find more articles like this one

I'm here to research stocks

Ask Meyka Analyst about any stock

I'm here to track my Portfolio

Get daily updates and alerts (coming March 2026)